Rashtriya Newsflash

Expansion & Investment Trends in Central & Eastern Europe Data Center – Existing & Upcoming Facilities Set to Transform Market – Arizton

Expansion & Investment Trends in Central & Eastern Europe Data Center – Existing & Upcoming Facilities Set to Transform Market – Arizton

Central & Eastern Europe Data Center – Existing & Upcoming Facilities Research by Arizton Discover Insights on 312 Data Center Facilities Across 4 Key Countries in Central & Eastern Europe

Read Full Article

Global Instrumentation Precision Parts Market to Reach USD 9.64 Billion by 2030: India and South Korea Lead Smart Factory Investments in High-Growth Regions | Arizton

U.S. Contract Catering Market Research Report by Arizton Industry Analysis Report, Regional Outlook, Growth Potential, Price Trends, Competitive Market Share & Forecast 2025–2030. According to Arizton research, the global instrumentation

Read Full Article

MetaTech and CM Plus Establish Strategic Partnership to Build “AI Katana” Platform for Biotech Market Expansion in Japan and Asia

TOKYO/TAIPEI – October 13, 2025 – MetaTech (AP) Inc. (TWSE: 3224), a leading Taiwanese biotech AI technology company, and CM Plus, a multinational enterprise specializing in high-standard engineering management and

Read Full Article

Bispecifics in Oncology Market Statistics Expected to Experience Major Growth by 2040, According to DelveInsight | AstraZeneca, I-MAB Biopharm, BioNTech, Bristol Myers Squibb

The Key Bispecifics in Oncology Companies in the market include – AstraZeneca, I-MAB Biopharma and BMS, BioNTech and Bristol Myers Squibb, and others. DelveInsight’s “Bispecifics in Oncology Market Insights, Epidemiology,

Read Full Article

Epidermolysis Bullosa Pipeline 2025: FDA Approvals and Clinical Trials Landscape with MOA and ROA Highlights by DelveInsight | RegeneRx Biopharma, BridgeBio Pharma, Berg Pharma, Holostem Terapie Avanz

Epidermolysis Bullosa pipeline constitutes 20+ key companies continuously working towards developing 21+ Epidermolysis Bullosa treatment therapies, analysis of Clinical Trials,

Read Full Article

AAV for the Hereditary Retinal Diseases Competitive landscape 2025: MOA, ROA, FDA-Approved Drugs, and Clinical Trial Progress Assessment By DelveInsight | Novartis, J&J, Beacon Therapeutics, 4D Molecu

(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, AAV for the Hereditary Retinal Diseases pipeline constitutes 75+ key

Read Full Article

7thClub Redefines White Label SEO with Smart AEO and GEO Strategies for Agencies

As Google’s AI-driven search updates reshape how brands appear online, 7thClub, a leading white label SEO agency, unveils a fresh

Read Full Article

BTK Inhibitor Market Growth to Accelerate in Forecast Period (2024-2034), DelveInsight Analyzes | Eli Lilly, Loxooncol, AstraZeneca, Beigene, Elli Lilly, Novartis, Ono pharma

The Key BTK Inhibitor Companies in the market include – Eli Lilly, Loxooncol, AstraZeneca, Beigene, Elli Lilly, Novartis, Ono pharmaceutical,

Read Full Article

T-cell receptor (TCR) Therapy Pipeline 2025: Therapies, MOA Insights, and Key Clinical Trial Updates by DelveInsight | MediGene AG, Adaptive Biotech, Cell Medica Ltd., Bellicum Pharma, Takara Bio

(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, T-cell receptor (TCR) Therapy pipeline constitutes key companies continuously working

Read Full Article

Cell And Gene Therapy For Multiple Myeloma Market Positioned for Accelerated Development Through 2032, DelveInsight Finds | J&J, Bristol Myers Squibb, Regeneron, AbbVie, Roche, Janssen Pharma

The Key Cell And Gene Therapy For Multiple Myeloma Companies in the market include – Johnson & Johnson Innovative Medicine,

Read Full Article